Development of lipid nano particles RNA vaccine against hepatitis B surface antigens of hepatitis B virus

Pattern of Lipid nanoparticle (LNP)- RNA vaccine against Haemophilus influenza type b hcsA and hcsB genes facilitating the transport of capsular polysaccharides across the outer

Development of Lipid Nanoparticles [LNP]-RNA Vaccine Against Neisseria Meningitidis CPS Gene Locus Facilitating the Synthesis of The Capsular Polysaccharide in Egypt

Development of lipid nanoparticles(LNP)- RNA vaccine against <i>Streptococcus pneumoniae</i> gene cluster facilitating the synthesis of the capsular polysaccharide in Egypt.

Design of Lipid nanoparticle (LNP)- RNA vaccine against Haemophilus influenza type b hcsA and hcsB genes facilitating the transport of capsular polysaccharides across the outer m

Efficacy of chitosan nanoparticles as adjuvant in development of an inactivated Newcastle Disease Virus(genotype VII) vaccine.

Using a Novel Nanoparticle as An Adjuvant for Inactivated Avian Influenza Vaccine

Emerging Trends in mRNA Vaccine Technology: Beyond Infectious Diseases

CATIONIC LIPID NANOEMULSION AS A DRUG DELIVERY SYSTEM IN CANCER AND VIRAL IMMUNOTHERAPY

Development of possible COVID-19 vaccine for elderly